Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating 611 for chronic rhinosinusitis with nasal polyps is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Sinusitis, Nasal Polyps | Phase 3 | Status: ACTIVE_NOT_RECRUITING